Return On Assets of Atara Biotherapeutics, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Atara Biotherapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Atara Biotherapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 39%.
  • Atara Biotherapeutics, Inc. annual Return On Assets for 2024 was -64%, a 48% increase from 2023.
  • Atara Biotherapeutics, Inc. annual Return On Assets for 2023 was -122%, a 111% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Return On Assets for 2022 was -58%, a 19% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Atara Biotherapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 39% +129% 01 Jul 2025 30 Sep 2025
Q2 2025 7% +120% 01 Apr 2025 30 Jun 2025
Q1 2025 -15% +107% +88% 01 Jan 2025 31 Mar 2025
Q4 2024 -64% +58% +48% 01 Oct 2024 31 Dec 2024
Q3 2024 -90% +14% +14% 01 Jul 2024 30 Sep 2024
Q2 2024 -114% -20% -21% 01 Apr 2024 30 Jun 2024
Q1 2024 -122% -64% -110% 01 Jan 2024 31 Mar 2024
Q4 2023 -122% -64% -111% 01 Oct 2023 31 Dec 2023
Q3 2023 -104% -45% -76% 01 Jul 2023 30 Sep 2023
Q2 2023 -94% -38% -67% 01 Apr 2023 30 Jun 2023
Q1 2023 -58% +21% +27% 01 Jan 2023 31 Mar 2023
Q4 2022 -58% +14% +19% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% +6% +8.7% 01 Jul 2022 30 Sep 2022
Q2 2022 -57% +8% +12% 01 Apr 2022 30 Jun 2022
Q1 2022 -79% -15% -24% 01 Jan 2022 31 Mar 2022
Q4 2021 -71% 0% -0.27% 01 Oct 2021 31 Dec 2021
Q3 2021 -65% +18% +21% 01 Jul 2021 30 Sep 2021
Q2 2021 -64% +20% +24% 01 Apr 2021 30 Jun 2021
Q1 2021 -64% +29% +31% 01 Jan 2021 31 Mar 2021
Q4 2020 -71% +18% +20% 01 Oct 2020 31 Dec 2020
Q3 2020 -82% +4% +4.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -84% -6% -7.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -93% -31% -50% 01 Jan 2020 31 Mar 2020
Q4 2019 -89% -38% -74% 01 Oct 2019 31 Dec 2019
Q3 2019 -86% -41% -89% 01 Jul 2019 30 Sep 2019
Q2 2019 -78% -33% -73% 01 Apr 2019 30 Jun 2019
Q1 2019 -62% -15% -33% 01 Jan 2019 31 Mar 2019
Q4 2018 -51% 0% -0.08% 01 Oct 2018 31 Dec 2018
Q3 2018 -46% -4% -9.4% 01 Jul 2018 30 Sep 2018
Q2 2018 -45% -8% -20% 01 Apr 2018 30 Jun 2018
Q1 2018 -46% -14% -44% 01 Jan 2018 31 Mar 2018
Q4 2017 -51% -24% -88% 01 Oct 2017 31 Dec 2017
Q3 2017 -42% -15% -56% 01 Jul 2017 30 Sep 2017
Q2 2017 -37% -16% -74% 01 Apr 2017 30 Jun 2017
Q1 2017 -32% -10% -42% 01 Jan 2017 31 Mar 2017
Q4 2016 -27% -4% -18% 01 Oct 2016 31 Dec 2016
Q3 2016 -27% -3% -12% 01 Jul 2016 30 Sep 2016
Q2 2016 -21% +12% +35% 01 Apr 2016 30 Jun 2016
Q1 2016 -23% 01 Jan 2016 31 Mar 2016
Q4 2015 -23% 01 Oct 2015 31 Dec 2015
Q3 2015 -24% 01 Jul 2015 30 Sep 2015
Q2 2015 -33% 01 Apr 2015 30 Jun 2015

Atara Biotherapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -64% +58% +48% 01 Jan 2024 31 Dec 2024
2023 -122% -64% -111% 01 Jan 2023 31 Dec 2023
2022 -58% +14% +19% 01 Jan 2022 31 Dec 2022
2021 -71% 0% -0.27% 01 Jan 2021 31 Dec 2021
2020 -71% +18% +20% 01 Jan 2020 31 Dec 2020
2019 -89% -38% -74% 01 Jan 2019 31 Dec 2019
2018 -51% 0% -0.08% 01 Jan 2018 31 Dec 2018
2017 -51% -24% -88% 01 Jan 2017 31 Dec 2017
2016 -27% -4% -18% 01 Jan 2016 31 Dec 2016
2015 -23% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.